COMPANY OVERVIEW
Total Bio Solution Partner

BNF Solution is a biotechnology-based manufacturing company specializing in bioactive ingredients and dermacosmetic products centered on PDRN/PN. We independently manage the entire process from raw material extraction to final product manufacturing and supply high-quality bio-products to the global market through OEM/ODM partnerships with domestic and international clients.


END TO END CONTROL

From raw materials to finished products

Manufacturing Infrastructure

Annual PDRN/PN Production

200 kg

BNF Solution has an annual production capacity of approximately 200 kg of PDRN/PN, delivering consistently high-quality raw materials suitable for a wide range of applications across medical, aesthetic, and other specialized fields.


Annual OEM/ODM Product Manufacturing

500,000 units

With an annual production capacity of over 500,000 units, we ensure stable and efficient manufacturing from small-batch orders to large-scale production.

In-house operation of aquaculture farms and raw material production facilities

BNF Solution directly cultivates trout in Pyeongchang, Gangwon Province, overseeing every step from fertilization and aquaculture of male trout to DNA extraction and final product manufacturing. We uphold stringent quality standards throughout the entire process, ensuring that our customers receive safe, reliable raw materials and finished products. Providing trustworthy quality is our highest priority.

*HACCP Certification by the Ministry of Oceans and Fisheries

*Compliance with pharmaceutical-grade raw material manufacturing standards

*Operation of GMP-level hygiene and quality management systems


COMPANY OVERVIEW

Total Bio Solution Partner

Over 99% DNA purity

BNF Solution’s PDRN/PN boasts exceptional quality, with a DNA purity of over 99%. Through proprietary production expertise and high-purity extraction technology, we offer customized manufacturing optimized for a wide range of applications. Our strict quality control and continuous R&D efforts have earned global recognition for the excellence of our raw materials.

*COA provided

*No detection across 82 test items, including allergens, lead, arsenic, and bacteria

BNF Solution is a biotechnology-based manufacturing company specializing in bioactive ingredients and dermacosmetic products centered on PDRN/PN. We independently manage the entire process from raw material extraction to final product manufacturing and supply high-quality bio-products to the global market through OEM/ODM partnerships with domestic and international clients.



END TO END CONTROL

From raw materials to finished products

Manufacturing Infrastructure


Annual PDRN/PN Production

200 kg

BNF Solution has an annual production capacity of approximately 200 kg of PDRN/PN, delivering consistently high-quality raw materials suitable for a wide range of applications across medical, aesthetic, and other specialized fields.


Annual OEM/ODM Product Manufacturing

500,000 units

With an annual production capacity of over 500,000 units, we ensure stable and efficient manufacturing from small-batch orders to large-scale production.

In-house operation of aquaculture farms and raw material production facilities

BNF Solution directly cultivates trout in Pyeongchang, Gangwon Province, overseeing every step from fertilization and aquaculture of male trout to DNA extraction and final product manufacturing. We uphold stringent quality standards throughout the entire process, ensuring that our customers receive safe, reliable raw materials and finished products. Providing trustworthy quality is our highest priority.

*HACCP Certification by the Ministry of Oceans and Fisheries

*Compliance with pharmaceutical-grade raw material manufacturing standards

*Operation of GMP-level hygiene and quality management systems


Over 99% DNA purity

BNF Solution’s PDRN/PN boasts exceptional quality, with a DNA purity of over 99%. Through proprietary production expertise and high-purity extraction technology, we offer customized manufacturing optimized for a wide range of applications. Our strict quality control and continuous R&D efforts have earned global recognition for the excellence of our raw materials.

*COA provided

*No detection across 82 test items, including allergens, lead, arsenic, and bacteria

History

2025

- Patent acquired for proprietary PDRN extraction process [No. 10-2853342]
- Patent acquired for PDRN-based exosome cosmetic composition [No. 10-2856650]
- Patent acquired for skin booster manufacturing method using PN, NMN, and NAD⁺ stabilization technology [No. 10-2796496]
- Patent acquired for skin booster composition with superior skin-improving effects [No. 10-2867149]

2024

- ISO 13485 Certification (Medical Devices)
- ISO 22716 Certification (Cosmetics)

2023

- Operating OEM/ODM manufacturing for export-grade fillers and skin boosters
- Mass production and supply of high-purity PDRN/PN
- Overseas export approval acquired for BelleGen fillers (RESCUE/MAGIC)

2022

- Launched BelleGen, BNF Solution’s own brand
- Developed extraction technology for proteoglycans from trout non-cartilaginous tissue
- Completed construction of the PDRN/PN raw material production facility at the Pyeongchang headquarters
- Completed construction of the GMP filler manufacturing facility at the Anyang branch

2021

- Signed a technology transfer agreement with Yonsei University for PDRN encapsulation in exosomes and enhanced skin absorption—4th joint industry–academia development projec
- Secured Series-A RCPS investment
- Signed an MOU with Kyperion Co., Ltd. for joint filler supply

2020

- Secured 2nd RCPS investment from POSCO NSC Fisheries Investment Fund
- Developed exosome cultivation and extraction technology using skin cells, and PDRN encapsulation technology — 3rd joint industry–academia project with Yonsei University
- Signed an agreement with Reyon Pharm Co., Ltd. for PDRN raw material supply and DNA extraction technology transfer

2019

- Established BNF Solution’s company-affiliated research institute at the Anyang branch / Obtained Venture Business Certification
- Secured 1st RCPS investment from POSCO NSC Fisheries Investment Fund
- Secured growth-sharing investment from the Small and Medium Business Corporation (SBC)
- Developed technology to enhance skin absorption of PDRN-based solutions — 2nd joint industry–academia project with Yonsei University
- Selected as a Promising Marine Bio Startup by the Ministry of Oceans and Fisheries

2018

Commercialization of trout-derived PDRN extraction and formulation technology — 1st joint industry–academia project with Yonsei University

2016

Development of PDRN/PN extraction technology from trout and salmon reproductive cells

2015

- Entered the trout aquaculture business
- Conducted genetic breeding research for aquatic seed production

2013

Founded BNF Solution Co., Ltd.

History

2025

- Patent acquired for proprietary PDRN extraction process [No. 10-2853342]
- Patent acquired for PDRN-based exosome cosmetic composition [No. 10-2856650]
- Patent acquired for skin booster manufacturing method using PN, NMN, and NAD⁺ stabilization technology [No. 10-2796496]
- Patent acquired for skin booster composition with superior skin-improving effects [No. 10-2867149]

2024

- ISO 13485 Certification (Medical Devices)
- ISO 22716 Certification (Cosmetics)

2023

- Operating OEM/ODM manufacturing for export-grade fillers and skin boosters
- Mass production and supply of high-purity PDRN/PN
- Overseas export approval acquired for BelleGen fillers (RESCUE/MAGIC)

2022

- (Launched BelleGen, BNF Solution’s own brand
- Developed extraction technology for proteoglycans from trout non-cartilaginous tissue
- Completed construction of the PDRN/PN raw material production facility at the Pyeongchang headquarters
- Completed construction of the GMP filler manufacturing facility at the Anyang branch

2021

- Signed a technology transfer agreement with Yonsei University for PDRN encapsulation in exosomes and enhanced skin absorption—4th joint industry–academia development project
- Secured Series-A RCPS investment
- Signed an MOU with Kyperion Co., Ltd. for joint filler supply

2020

- Secured 2nd RCPS investment from POSCO NSC Fisheries Investment Fund
- Developed skin-cell–derived exosome cultivation and PDRN encapsulation technology
- Signed an agreement with Reyon Pharm Co., Ltd. for PDRN raw material supply and technology transfer

2019

- Established company-affiliated research institute and obtained Venture Business Certification
- Secured 1st RCPS investment from the Fisheries Investment Fund
- Secured growth-sharing investment from the Small and Medium Business Corporation (SBC)
- Developed technology to enhance PDRN absorption
- Selected as a promising marine bio startup

2018

Commercialization of trout-derived PDRN extraction and formulation technology

2016

Development of PDRN/PN extraction technology from trout and salmon reproductive cells

2015

- Entered the trout aquaculture business
- Conducted genetic breeding research for aquatic seed production

2013

Founded BNF Solution Co., Ltd.

BNF Solution Patents & Certifications

BNF Solution Co., Ltd.  l  CEO : Min-Tae Kim

Business Registration Number : 806-85-01234

Tel : +82 31-425-2234

COPYRIGHT ⓒ BNF SOLUTION ALL RIGHTS RESERVED.

상호명 : (주)비앤에프솔루션   l  대표 : 김민태  l  사업자등록번호 : 806-85-01234  l  전화번호 : 031-425-2234

COPYRIGHT ⓒ BNF SOLUTION ALL RIGHTS RESERVED.